• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.66% Nasdaq Down 1.05%

    More On RDHL

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    Financials

    RedHill Biopharma Ltd. (RDHL)

    -NasdaqCM
    12.97 Down 0.21(1.59%) 3:59PM EDT
    Add to Portfolio
    Prev Close:13.18
    Open:12.83
    Bid:12.74 x 400
    Ask:12.95 x 100
    1y Target Est:31.50
    Beta:-0.600641
    Next Earnings Date:N/A
    Day's Range:12.01 - 13.07
    52wk Range:6.89 - 22.22
    Volume:28,792
    Avg Vol (3m):115,740
    Market Cap:128.96M
    P/E (ttm):N/A
    EPS (ttm):-2.31
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for RDHL

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):18,721.25
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-2.37
    Quarterly EPS Est (Sep-15) :-0.61
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    RedHill Biopharma Ltd., a biopharmaceutical company, focuses on the development and acquisition of late clinical-stage, proprietary, and orally-administered drugs for the treatment of inflammatory and gastrointestinal diseases, including gastroint... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback